RNA
#3518
Atrium Therapeutics, Inc. - Common Stock
13.7 6 USD
-0.02%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.57%
Monthly Change
+20.60%
6 month change
-0.36%
Year Change
-80.44%
Previous Close
13.9 8
Open
13.8 7
Low
13.7 6
High
13.9 5
Volume
13
Financials
- Market Capitalization 235.37 M
- Employee 391
- Founded 2025
- CEO Troy Wilson
- Website www.aviditybiosciences.com
- Headquarter Delaware, United States
- FIGI BBG01Z0T3959
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3490 |  NERV Minerva Neurosciences, Inc - Common Stock | 5.13 USD | -5.52% | +2.40% | +19.86% | +111.98% | 244.94 M USD | ||
| 3496 |  PRQR ProQR Therapeutics N.V. - Ordinary Shares | 2.31 USD | -0.43% | -2.12% | +31.25% | +5.00% | 243.38 M USD | ||
| 3526 |  TNXP Tonix Pharmaceuticals Holding Corp. - Common Stock | 13.57 USD | +0.07% | +7.53% | +35.70% | -9.59% | 232.74 M USD | ||
| 3546 |  TARA Protara Therapeutics, Inc. - Common Stock | 3.87 USD | -3.01% | -0.51% | -0.77% | +22.47% | 228.70 M USD |
Frequently asked questions about Atrium Therapeutics, Inc. Common Stock
What is the Atrium Therapeutics, Inc. Common Stock stock price today?
The current price of Atrium Therapeutics, Inc. Common Stock (RNA) is 13.76. Over the past 24 hours, the stock has changed by -1.57%. Follow the RNA chart for real-time price dynamics.
What is the stock ticker of Atrium Therapeutics, Inc. Common Stock?
Atrium Therapeutics, Inc. Common Stock trades under the ticker RNA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Atrium Therapeutics, Inc. Common Stock stock going up?
RNA has changed by +3.69% over the last week, +20.60% over the last month, and -80.44% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Atrium Therapeutics, Inc. Common Stock?
Atrium Therapeutics, Inc. Common Stock currently has a market capitalization of 235.37 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Atrium Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Atrium Therapeutics, Inc. Common Stock reported earnings of -1.18 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Atrium Therapeutics, Inc. Common Stock revenue for the last quarter?
Atrium Therapeutics, Inc. Common Stock reported quarterly revenue of 3 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Atrium Therapeutics, Inc. Common Stock net income for the last quarter?
Atrium Therapeutics, Inc. Common Stock reported net income of -20.19 M for the last quarter. The previous quarter showed -16.63 M, which means net income changed by -21.36%.
How many employees does Atrium Therapeutics, Inc. Common Stock have?
As of the latest available data, Atrium Therapeutics, Inc. Common Stock has 391 employees. Workforce size can provide additional context about the company's scale and operations.
What is Atrium Therapeutics, Inc. Common Stock EBITDA?
Atrium Therapeutics, Inc. Common Stock EBITDA is -22.27 M, and its EBITDA margin is -741.51%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Atrium Therapeutics, Inc. Common Stock stock?
You can buy Atrium Therapeutics, Inc. Common Stock (RNA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Atrium Therapeutics, Inc. Common Stock stock?
Investing in Atrium Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RNA chart and related analysis on metatrader.com as part of your research.